PRRT Neuroendocrine Tumor Response monitored using Circulating Transcript Analysis: The NETest

PURPOSE: Peptide receptor radionuclide therapy (PRRT) is effective for metastatic/inoperable neuroendocrine tumors (NETs). Imaging response assessment is usually efficient subsequent to treatment completion. Blood biomarkers such as PRRT Predictive Quotient (PPQ) and NETest are effective in real-tim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Nucl Med Mol Imaging
Main Authors: Bodei, Lisa, Kidd, Mark S., Singh, Aviral, van der Zwan, Wouter A., Severi, Stefano, Drozdov, Ignat A., Malczewska, Anna, Baum, Richard P., Kwekkeboom, Dik J, Paganelli, Giovanni, Krenning, Eric P., Modlin, Irvin M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7515632/
https://ncbi.nlm.nih.gov/pubmed/31838581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-019-04601-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados